Triglycerides are not directly atherogenic, but represent an important biomarker of cardiovascular disease risk because of their association with atherogenic remnant particles and apolipoprotein C-III, a lipoprotein lipase (LPL) inhibitor[24]. The gene discussed is APOC3; the disease is cardiovascular disorder.